NMDA receptor antagonism is widely employed to model the glutamatergic hypofunction believed to underlie cognitive deficits in schizophrenia. Non-competitive antagonists such as MK-801 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results